FDA Enforcement
Class II
Terminated
Stingray" Guidewire, labeled as 300cm. intended to facilitate placement of balloon dilatation catheters or other intravascular devices during percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA).
Recall: Z-0852-2019
·
Reported February 27, 2019
Enforcement
- Recall Number
- Z-0852-2019
- Event ID
- 81863
- Classification
- Class II
- Status
- Terminated
- Product Type
- Devices
- Firm
- Boston Scientific Corporation
- Voluntary / Mandated
- Voluntary: Firm initiated
- Initial Notification
- Letter
- Report Date
- February 27, 2019
- Initiation Date
- December 19, 2018
- Classification Date
- February 20, 2019
- Termination Date
- June 9, 2020
- Address
- 1 Scimed Pl, Maple Grove, MN, 55311-1565, United States
Description
Stingray" Guidewire, labeled as 300cm. intended to facilitate placement of balloon dilatation catheters or other intravascular devices during percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA).
Reason
A batch of 185cm Stingray Guidewires are incorrectly labeled as 300cm guidewires.
Code Info
Material Number (UPN) H749M3004A0, Batch Number 21558994, Expiration Date 11/30/2019
Distribution
Nationwide distribution to AR, CT, FL, IA, IL, IN, KY, MA, MI, ND, NJ, NY, OH, OK, PA, SC, TX, VA, WI, WY.
Quantity
49 units